Angiotensin blockade for hypertension: a promise fulfilled.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Impact of Antihypertensive Drug Class on Outcomes in SPRINT.Hypertension (Dallas, Tex. : 1979) · 2022
   Trial
2. Putting LIFE into hypertension.Current hypertension reports · 2002
   Trial
3. Soluble (Pro)renin Receptor Is Adversely Associated with Indices of Left Ventricular Structure and Function: The African-PREDICT Study.Journal of cardiovascular development and disease · 2022
   Article
4. Obesity and statins are both independent predictors of enhanced coronary arteriolar dilation in patients undergoing heart surgery.Journal of cardiothoracic surgery · 2013
   Article
5. An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies.Journal of computer-aided molecular design · 2010
   Article
6. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway.Molecular and cellular biochemistry · 2009
   Article
7. Angiotensin converting enzyme activity in infancy is related to birth weight.Archives of disease in childhood. Fetal and neonatal edition · 2004
   Article
8. Ace revisited: a new target for structure-based drug design.Nature reviews. Drug discovery · 2003
   Review
9. Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.British journal of clinical pharmacology · 2003
   Review
10. Practising communication skills.The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article
11. The Aussie consultation.The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article
12. Computers and consumerism in UK general practice: learning from the Australian experience.The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article
13. Time to reverse that altruism bypass...The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article
14. Believe me, public involvement does work--honest!The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article
15. Myalgic encephalomyelitis--the dangers of Cartesian fundamentalism.The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
    Article

Corrections and comments

• Commented on by
  Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.2002

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as